In silico methods for unraveling the mechanistic complexities of intestinal absorption: Metabolism-efflux transport interactions

Drug Metabolism and Disposition

Volumn 36, Issue 7, 2008, Pages 1414-1424

  Garmire, Lana X ^a   Hunt, C Anthony ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c San Francisco   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; DRUG METABOLIZING ENZYME; GLYCOPROTEIN P;

ARTICLE; BINDING AFFINITY; DEVICE; DIFFUSION COEFFICIENT; FLOW RATE; IN SILICO INTESTINAL DEVICE; INTESTINE ABSORPTION; INTESTINE TRANSIT TIME; METABOLISM; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SIMULATION;

BIOLOGICAL TRANSPORT; CYTOCHROMES; INTESTINAL ABSORPTION;

EID: 46449103183     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.107.020164     Document Type: Article

References (9)

1. Cao X, Gibbs ST, Fang L, Miller HA, Landowski CP, Shin HC, Lennernas H, Zhong Y, Amidon GL, Yu LX, et al. (2006) Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model. Pharm Res 23:1675-1686.
2. Cormen TH, Leiserson CE, and Rivest RL (1990) Introduction to Algorithms, Mcgraw-Hill, New York.
3. Cummins CL, Jacobsen W, and Benet LZ (2002) Unmasking the dynamic interplay between intestinal P-glycoprotein and CYP3A4. J Pharmacol Exp Ther 300:1036-1045.
4. Cummins CL, Salphati L, Reid MJ, and Benet LZ (2003) In vivo modulation of intestinal CYP3A metabolism by P-glycoprotein: studies using the rat single-pass intestinal perfusion model. J Pharmacol Exp Ther 305:306-314.
5. Dokoumetzidis A, Kalantzi L, and Fotaki N (2007) Predictive models for oral drug absorption: from in silico methods to integrated dynamical models. Exp Opin Drug Metab Toxicol 3:491-505.
6. Englund G, Rorsman F, Ronnblom A, Karlbom U, Lazorova L, Grasjo J, Kindmark A, and Artursson P (2006) Regional levels of drug transporters along the human intestinal tract: co-expression of ABC and SLC transporters and comparison with CACO-2 cells. Eur J Pharm Sci 29:269-277.
7. Fisher J and Henzinger TA (2007) Executable cell biology. Nat Biotechnol 25:1239-1249.
8. Freitas Jr RA (1999) Nanomedicine, Volume I: Basic Capabilities, Landes Bioscience, Georgetown, TX.
9. Gan LS, Moseley MA, Khosla B, Augustijns PF, Bradshaw TP, Hendren RW, Thakker DR (1996) CYP3A-like cytochrome P450-mediated metabolism and polarized efflux of cyclosporin a in CACO-2 cells. Drug Metab Dispos 24:344-349.